Three of the samples show frequencies of greater than 50%, which suggests that copy number amplification of the KRAS locus has occurred in these samples and that simply doubling the KRAS frequency will overestimate the tumor’s cellularity—a limitation of this approach. This evidence concerns the gene KRAS and neoplasm.